Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor mo

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2005-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.IJROBP.2004.12.057PMID 15817355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Copper homeostasis: the role of cellular transporters.

  2009cited by this paper
• Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.

  2005cited by this paper
• Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer

  2004cited by this paper
• Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.

  2003cited by this paper
• Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning

  2003cited by this paper
• In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM

  2003cited by this paper
• Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

  2002cited by this paper
• Measurements of Tumor Tissue Oxygen Tension Using a Time-Resolved Luminescence-Based Optical OxyLite Probe: Comparison with a Paired Survival Assay

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

  2002cited by this paper
• [18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure.

  2001cited by this paper
• Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemia.

  2001cited by this paper
• Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.

  2001cited by this paper
• Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation.

  2001cited by this paper
• Relationship of hypoxia to metastatic ability in rodent tumours

  2001cited by this paper
• Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET.

  2001cited by this paper
• Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis

  2000cited by this paper
• Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.

  1999cited by this paper
• Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats.

  1999cited by this paper
• Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays.

  1998cited by this paper
• The synthesis and radiolabelling of novel markers of tissue hypoxia of the iodinated azomycin nucleoside class.

  1997cited by this paper
• Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.

  1997cited by this paper
• Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck.

  1997cited by this paper
• Copper radionuclides and radiopharmaceuticals in nuclear medicine.

  1996cited by this paper
• Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

  1996cited by this paper
• Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

  1996cited by this paper
• Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

  1996cited by this paper
• Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients.

  1996cited by this paper
• Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside.

  1996cited by this paper
• Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia.

  1995cited by this paper
• Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity.

  1994cited by this paper
• Intratumoral pO2 histography as predictive assay in advanced cancer of the uterine cervix.

  1994cited by this paper
• Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements.

  1991cited by this paper
• Oxygenation of human tumors.

  1990cited by this paper
• R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate cancer.

  1977cited by this paper
• A new human cell line (FaDu) from a hypopharyngeal carcinoma

  1972cited by this paper
• The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy

  1955cited by this paper

• Hypoxia Inducible Factor-1α Specific Probe for Tumor Hypoxia Positron Emission Tomography Imaging.

  2025cites this paper
• Positron emission tomography imaging sheds new light on hypoxia and antitumor therapies

  2023cites this paper
• Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases

  2023cites this paper
• Four-dimensional quantitative analysis using FDG-PET in clinical oncology

  2023cites this paper
• Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?

  2022cites this paper
• The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia

  2022cites this paper
• [64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation

  2022cites this paper
• Review on Radiation Therapy on Cancer

  2022cites this paper
• Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose

  2022cites this paper
• Photoactivatable bis(thiosemicarbazone) derivatives for copper-64 radiotracer synthesis

  2022cites this paper
• 64Cu-ATSM Predicts Efficacy of Carbon Ion Radiotherapy Associated with Cellular Antioxidant Capacity

  2021cites this paper
• In vivo noninvasive preclinical tumor hypoxia imaging methods: a review

  2021influential citation
• Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer

  2020cites this paper
• The clinical utility of imaging methods used to measure hypoxia in cervical cancer.

  2020cites this paper
• Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions.

  2020cites this paper
• Radionuclide generators: the prospect of availing PET radiotracers to meet current clinical needs and future research demands.

  2019cites this paper
• Volumetric optoacoustic imaging unveils high-resolution patterns of acute and cyclic hypoxia in a murine model of breast cancer.

  2019cites this paper
• Examining correlations of oxygen sensitive MRI (BOLD/TOLD) with [18F]FMISO PET in rat prostate tumors.

  2019cites this paper
• Prognostic implications of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/CT in patients with glioma

  2018cites this paper
• Clinical imaging of hypoxia: Current status and future directions

  2018cites this paper
• How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research

  2018cites this paper
• Early and delayed evaluation of solid tumours with 64Cu-ATSM PET/CT: a pilot study on semiquantitative and computer-aided fractal geometry analysis

  2017cites this paper
• PET-CT, Bio-imaging for Predicting Prognosis and Response to Chemotherapy in Patients with Lung Cancer

  2017cites this paper
• Hypoxia in Head and Neck Cancer

  2017cites this paper
• PET/MR imaging of hypoxic atherosclerotic plaque using 64Cu-ATSM

  2017cites this paper
• Copper-64 radiopharmaceuticals for PET imaging of copper trafficking in neurological disorders

  2017cites this paper
• Hypoxia PET imaging techniques: data acquisition and analysis

  2017influential citation
• Hypoxia in cervical cancer: from biology to imaging

  2017cites this paper
• Molecular mechanisms of hypoxia in cancer

  2017cites this paper
• Imageable Biomarkers for Radiotherapy Response.

  2017cites this paper
• Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical Settings

  2017cites this paper
• Innovative Radiopharmaceuticals in Oncology and Neurology

  2017cites this paper
• Carbon Nanotubes and Related Nanohybrids Incorporating Inorganic Transition Metal Compounds and Radioactive Species as Synthetic Scaffolds for Nanomedicine Design:Chapter Eight

  2017cites this paper
• Biophysical characterization and antineoplastic activity of new bis(thiosemicarbazonato) Cu(II) complexes.

  2017cites this paper
• FMISO as a Biomarker for Clinical Radiation Oncology.

  2016cites this paper
• Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET

  2016cites this paper
• Imaging of tumor hypoxia with PET : a step towards individualized cancer treatment

  2016influential citation
• Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO).

  2016cites this paper
• Hypoxia Imaging with 18F-FMISO PET for Brain Tumors

  2016cites this paper
• Tumor hypoxia: a new PET imaging biomarker in clinical oncology

  2016cites this paper
• Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.

  2016cites this paper
• Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging.

  2016cites this paper
• Hypoxia Image Guided Radiation Therapy: Current Status and Major Challenges

  2016cites this paper
• Hypoxia as a Biomarker and for Personalized Radiation Oncology.

  2016cites this paper
• Perspectives on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy

  2016cites this paper
• (18)F-fluoromisonidazole PET reveals spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer.

  2015cites this paper
• The hypoxic tumor microenvironment: from imaging to targeting

  2015cites this paper
• A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].

  2015cites this paper
• PET AND MRI-GUIDED FOCUSED ULTRASOUND SURGERY FOR HYPOXIC-TISSUE ABLATION COMBINED WITH RADIOTHERAPY IN SOLID TUMORS

  2015cites this paper
• Measurement of hypoxia-related parameters in three sublines of a rat prostate carcinoma using dynamic (18)F-FMISO-Pet-Ct and quantitative histology.

  2015cites this paper
• PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma.

  2015cites this paper
• 64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2

  2015cites this paper
• spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer

  2015cites this paper
• Focus on the Controversial Aspects of 64Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging

  2015cites this paper
• Imaging radiation response in tumor and normal tissue.

  2015cites this paper
• Molecular imaging of hypoxia in non-small-cell lung cancer

  2015cites this paper
• Development of PET probes for cancer imaging.

  2015cites this paper
• Pharmacokinetic Analysis of 64Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice

  2015cites this paper
• A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.

  2015cites this paper
• Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles.

  2015cites this paper
• Quantification and clinical applicability of novel oncology PET imaging biomarkers

  2015cites this paper
• PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging

  2015cites this paper
• Review Article Kinetic modeling in PET imaging of hypoxia

  2014cites this paper
• Positron emission tomography to assess hypoxia and perfusion in lung cancer.

  2014cites this paper
• Kinetic modeling in PET imaging of hypoxia.

  2014cites this paper
• Detailed assessment of gene activation levels by multiple hypoxia-responsive elements under various hypoxic conditions

  2014cites this paper
• Imaging tumour hypoxia with positron emission tomography

  2014cites this paper
• Clinical Imaging of Hypoxia

  2014cites this paper
• Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study

  2014cites this paper
• Hypoxia as a biomarker for radioresistant cancer stem cells

  2014cites this paper
• Radiocopper for the imaging of copper metabolism.

  2014cites this paper
• Molecular Imaging of Tumor Hypoxia with Positron Emission Tomography

  2014cites this paper
• Preclinical Visualization of Hypoxia, Proliferation and Glucose Metabolism in Non-small Cell Lung Cancer and Its Metastasis

  2014cites this paper
• Radiolabelled probes targeting tumor hypoxia for personalized medicine.

  2014cites this paper
• On the Destiny of (Copper) Species

  2014cites this paper
• PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

  2014cites this paper
• A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers

  2014cites this paper
• Quelle imagerie pour la prise en charge de la rechute biochimique du cancer de la prostate : TEP ou IRM ?

  2014cites this paper
• A Comparison of the Behavior of 64Cu-Acetate and 64Cu-ATSM In Vitro and In Vivo

  2014cites this paper
• Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

  2014cites this paper
• Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.

  2014cites this paper
• [Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].

  2014cites this paper
• Targeting EGFR and VEGFR2 Tyrosine Kinases with Positron Emission Tomography - Evaluation of two Radiotracers

  2013cites this paper
• Modelling and Simulation of Hypoxia Imaging with Positron Emission Tomography

  2013cites this paper
• Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer

  2013cites this paper
• Radiopharmaceuticals for Imaging in Oncology with Special Emphasis on Positron-Emitting Agents

  2013cites this paper
• Evaluation of hypoxia in a feline model of head and neck cancer using 64Cu-ATSM positron emission tomography/computed tomography

  2013influential citation
• micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings

  2013cites this paper
• (18)F-misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings.

  2013cites this paper
• - ATSM In Vitro and In Vivo 64 Cu-Acetate and 64 A Comparison of the Behavior of

  2013cites this paper
• F-misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer : a correlation with autoradiography and histological findings

  2013cites this paper
• A model System for Validation of PET Radiopharmaceuticals: Focusing on Tumor Microenvironment

  2013cites this paper
• Preclinical molecular imaging using PET and MRI.

  2013cites this paper
• Usefulness of FMISO—PET for Glioma Analysis

  2013cites this paper
• Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study

  2013cites this paper
• Application of 62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET Imaging to Predict Highly Malignant Tumor Grades and Hypoxia-Inducible Factor-1α Expression in Patients with Glioma

  2013cites this paper
• Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment.

  2013cites this paper
• Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography.

  2013cites this paper
• PET of Hypoxia: Current and Future Perspectives

  2012cites this paper
• Single-fraction simulation of relative cell survival in response to uniform versus hypoxia-targeted dose escalation

  2012cites this paper